Alcon Eye-Drop Patents Survive Invalidity Appeal
A London appeals court on Tuesday upheld Alcon's patent for eye drops used to treat glaucoma, rejecting a generic-drug maker's argument that the intellectual property was obvious given earlier publications....To view the full article, register now.
Already a subscriber? Click here to view full article